share_log

科濟藥業-B:建議修訂組織章程細則及採納第八次經修訂及重述組織章程大綱及細則

CARSGEN-B: PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE EIGHTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

香港交易所 ·  Mar 26 07:37
Summary by Moomoo AI
科濟藥業控股有限公司(「科濟藥業-B」)於2024年3月26日宣布,董事會提出修訂組織章程細則,以符合香港聯合交易所有限公司證券上市規則,特別是關於2023年12月31日起上市發行人須以電子方式向證券持有人發佈公司通訊的新規定。此外,董事會亦建議採納經修訂及重述的組織章程大綱及細則,其中包含所有建議的細則修訂。這些修訂和採納將須在即將召開的股東週年大會上獲得股東通過特別決議案的批准後方可實施。相關通函和股東週年大會通告將於香港聯合交易所有限公司網站及科濟藥業官方網站公布。
科濟藥業控股有限公司(「科濟藥業-B」)於2024年3月26日宣布,董事會提出修訂組織章程細則,以符合香港聯合交易所有限公司證券上市規則,特別是關於2023年12月31日起上市發行人須以電子方式向證券持有人發佈公司通訊的新規定。此外,董事會亦建議採納經修訂及重述的組織章程大綱及細則,其中包含所有建議的細則修訂。這些修訂和採納將須在即將召開的股東週年大會上獲得股東通過特別決議案的批准後方可實施。相關通函和股東週年大會通告將於香港聯合交易所有限公司網站及科濟藥業官方網站公布。
KOJI PHARMACEUTICAL HOLDINGS LIMITED (“KOJI PHARMACEUTICAL-B”) ANNOUNCED ON 26 MARCH 2024 THAT ITS BOARD OF DIRECTORS HAS PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION IN ORDER TO COMPLY WITH THE RULES ON THE LISTING OF SECURITIES OF THE HONG KONG STOCK EXCHANGE LIMITED, IN PARTICULAR REGARDING ISSUERS TO BE ISSUED ELECTRONICALLY TO SECURITIES HOLDERS FROM 31 DECEMBER 2023 New rules for corporate communications. In addition, the Board of Directors proposes the adoption of a revised and revised Articles of Association and Conditions, including all proposed amendments to the terms and conditions. These amendments and adoption will be subject to the approval of a special resolution by shareholders at the upcoming Annual General Meeting. The relevant Circulars and Notice of the Annual General Meeting will be published on the website of the Hong Kong Stock Exchange Limited and on the official website of Kozai Pharmaceuticals.
KOJI PHARMACEUTICAL HOLDINGS LIMITED (“KOJI PHARMACEUTICAL-B”) ANNOUNCED ON 26 MARCH 2024 THAT ITS BOARD OF DIRECTORS HAS PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION IN ORDER TO COMPLY WITH THE RULES ON THE LISTING OF SECURITIES OF THE HONG KONG STOCK EXCHANGE LIMITED, IN PARTICULAR REGARDING ISSUERS TO BE ISSUED ELECTRONICALLY TO SECURITIES HOLDERS FROM 31 DECEMBER 2023 New rules for corporate communications. In addition, the Board of Directors proposes the adoption of a revised and revised Articles of Association and Conditions, including all proposed amendments to the terms and conditions. These amendments and adoption will be subject to the approval of a special resolution by shareholders at the upcoming Annual General Meeting. The relevant Circulars and Notice of the Annual General Meeting will be published on the website of the Hong Kong Stock Exchange Limited and on the official website of Kozai Pharmaceuticals.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more